4.7 Article

IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Precursor exhausted T cells: key to successful immunotherapy?

Axel Kallies et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

Xianjie Jiang et al.

MOLECULAR CANCER (2019)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Review Oncology

Safety of combining radiotherapy with immune-checkpoint inhibition

William L. Hwang et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Review Biochemistry & Molecular Biology

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

Miguel F. Sanmamed et al.

Article Cell Biology

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Angel Garcia-Diaz et al.

CELL REPORTS (2017)

Review Immunology

Mechanisms and consequences of Jak-STAT signaling in the immune system

Alejandro V. Villarino et al.

NATURE IMMUNOLOGY (2017)

Review Oncology

Combination cancer immunotherapies tailored to the tumour microenvironment

Mark J. Smyth et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Article Multidisciplinary Sciences

MYC regulates the antitumor immune response through CD47 and PD-L1

Stephanie C. Casey et al.

SCIENCE (2016)

Article Multidisciplinary Sciences

Identification of reference genes for circulating microRNA analysis in colorectal cancer

Yanqin Niu et al.

SCIENTIFIC REPORTS (2016)

Article Oncology

Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma

Yang Wen et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Biochemistry & Molecular Biology

The consensus molecular subtypes of colorectal cancer

Justin Guinney et al.

NATURE MEDICINE (2015)

Review Biochemistry & Molecular Biology

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway

Kim C. Ohaegbulam et al.

TRENDS IN MOLECULAR MEDICINE (2015)

Article Cell Biology

PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma

Jiajie Hou et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2015)

Article Medicine, General & Internal

Inactivation of MYC reverses tumorigenesis

Y. Li et al.

JOURNAL OF INTERNAL MEDICINE (2014)

Article Medicine, Research & Experimental

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

Yi-Teng Huang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2013)

Review Cell Biology

NF-kappa B and STAT3 - key players in liver inflammation and cancer

Guobin He et al.

CELL RESEARCH (2011)

Article Gastroenterology & Hepatology

Interleukin-22 Promotes Human Hepatocellular Carcinoma by Activation of STAT3

Runqiu Jiang et al.

HEPATOLOGY (2011)

Review Oncology

MYC as a regulator of ribosome biogenesis and protein synthesis

Jan van Riggelen et al.

NATURE REVIEWS CANCER (2010)

Review Oncology

MYC - TIMELINE Reflecting on 25 years with MYC

Natalie Meyer et al.

NATURE REVIEWS CANCER (2008)

Article Multidisciplinary Sciences

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

Willscott E. Naugler et al.

SCIENCE (2007)

Article Multidisciplinary Sciences

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

P Loke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

T Bowman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)